The NuLids Starter Kit – Nulids at-Home Dry Eye Treatment and Relief – Convenient & Easy to Use Handheld Device for Relief from Dry Eye, Blepharitis, MGD Symtpoms - Includes 30 Day Supply Of Soft Tips

Product Information

Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017;124(11S):S20-6. Bertino B, Blanchet-Réthoré S, Thibaut de Ménonville S, et al. Brimonidine displays anti-inflammatory properties in the skin through the modulation of the vascular barrier function. Exp Dermatol. 2018;27(12):1378-87. Intense pulsed light (IPL) involves targeting pigmented or vascular lesions with visible and infrared light, which, upon absorption, is converted to destructive heat. Though used primarily in dermatology for its FDA-approved indication of treating telangiectasias, IPL has more recently been used as an off-label treatment for evaporative dry eye mediated by MGD, often in patients who also suffer from rosacea. 31 IPL therapy involves direct application of 500 nm light to the skin, coagulating underlying blood vessels. Proposed mechanisms of efficacy include reduced inflammatory mediators and bacterial overgrowth by destruction of eyelid telangiectasias as well as melting of viscous meibum, allowing improved flow. 31

Next, instill lissamine green in the eye, wait 60 seconds for dispersal and allow the thin mucocutaneous junction (line of Marx) to stain. A stainless-steel golf club spud may be used to apply mild pressure while moving the spud in a lateral motion along this line. No anesthetic is indicated, as only mild pressure is required for debridement. When successfully completed, meibomian orifices should be exposed and there should be little to no oily sheen on the lid margin. 14 Today, there are a growing number of device-based therapies that help target the root causes of dryness. Here's a rundown of the latest technology used by ophthalmologists and other eye care providers to help soothe dry eyes. 'Deep cleaning' devices for dry eyes Mandal A, Gote V, Pal D, et al. Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa) for dry eye disease. Pharm Res. 2019;36(2):36.

'Deep cleaning' devices for dry eyes

Ocugen initiates phase 3 clinical trial of OCU310 for dry eye disease [press release]. Ocugen. October 1, 2018.

Lacrimal glands. Lacriprep (lacritin, TearSolutions) is another promising topical DED medication curently in clinical trials. It is a fragment of the lacritin protein, which is a glycoprotein released from the lacrimal glands. Research shows reduced levels of this protein are associated with dry eye signs. 31-33 Lacritin can promote basal tearing in eyes of rabbits and rescue cultured human corneal epithelial cells from inflammatory cytokine stress in dry eye patients. 33 A Phase II clinical trial of patients with Sjögren’s-associated DED is underway. 34 Ikervis (CsA 0.1%, Santen) and CyclASol (CsA 0.1%, Novaliq) may be future cyclosporine options in the United States. Ikervis, available in Europe, is a once-daily preservative-free formulation. 12 It is a cationic emulsion containing CsA that leads to the long-lasting presence of CsA in the tear film and a higher bioavailability than the anionic CsA formulation of Restasis. 12,13 As a result, with only once-daily dosing, Ikervis is well tolerated and significantly improves symptoms and signs of patients with severe DED by six months. 12,14

The majority of one study’s participants experienced immediate relief in lid tenderness following treatment, with improvements persisting for four weeks, with only 16% of patients requiring additional treatment. 17 Subsequent studies additionally showed relative growth of the meibomian glands via infrared meibography. Comparison of pre- and post-treatment images showed reversal of proximal atrophy with lengthening of shortened glands, increased density, partial restoration of glands and the appearance of new glands. 18 Growth was consistent for all degrees of gland atrophy. 18 While repeated probing is typically necessary, annual retreatment was adequate in these cases. 18 Shrivastava S, Patkar P, Ramakrishnan R, et al. Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes. Oman J Ophthalmol. 2018;11(3):207-12.

Xiao J, Adil MY, Olafsson J, et al. Diagnostic test efficacy of meibomian gland morphology and function. Sci Rep. 2019;9(1):17345. Dr. Akpek uses LipiFlow on a regular basis. “LipiFlow is expensive, but it’s also effective, especially for mild to moderate posterior blepharitis,” she says. “It’s a cleanup modality for resetting the glands. Its advantages are that it treats both the upper and lower lids and it’s painless. However, it does not treat anterior blepharitis, and in my experience, it does not work well for severe disease.” Keating GM. Diquafosol ophthalmic solution 3%: a review of its use in dry eye. Drugs. 2015;75(8):911-22.I’ve tried everything on the market for 10 years and read about NuLids but I was skeptical once again that it would work. I would say if you have eyelid issues due to dry eye – RUN don’t walk to get this product!!! I’ve used it a week and it has been terrific! Nancy M, Nulids user Toyos R, Briscoe D, Toyos M. The effects of red light technology on dry eye disease due to meibomian gland dysfunction. JOJ Ophthalmol. 2017;3(5):555624. Trehalose. This disaccharide with high water retention capabilities is naturally found in plants and animals and is both a bioprotectant and an osmoprotectant. 38,39 It protects corneal cells from the harmful effects of desiccation and tear hyperosmolarity—a hallmark of DED—by fortifying cell membranes and preventing the denaturation of proteins in the absence of water. 4,38,39 Research shows trehalose-containing artificial tears improve DED symptoms and signs, including the suppression of inflammation ( Figure 2). 40,41 Recently, three trehalose-containing artificial tears, Theratears Extra (Akorn), Refresh Optive Mega-3 (Allergan) and Thealoz Duo (Théa), entered the market with the potential to benefit DED patients beyond lubrication. Schaumberg DA, Nichols JJ, Papas EB, et al. The International Workshop on Meibomian Gland Dysfunction: report of the Subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994-2005. Robert M. Foster: The NuLids System is a unique, clinically validated, doctor prescribed, home-use treatment for meibomian gland dysfunction and blepharitis.